---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-005254"
form_type: "8-K"
ticker: "NNVC"
cik: "0001379006"
company_name: "NANOVIRICIDES, INC."
filed_at: "2024-01-19T23:59:59+00:00"
generated_at: "2026-06-06T21:10:50.540852+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# NanoViricides shareholders re-elect Anil Diwan as director, approve executive compensation and preferred stock grant

## Summary
- At the January 13, 2024 annual meeting, shareholders re-elected Anil Diwan as Class I director with 5,590,467 votes for, 308,092 against, 488,175 abstentions, and 3,056,966 broker non-votes.
- An advisory vote on named executive officer compensation passed with 5,572,378 votes for and 788,423 against, plus 3,056,966 broker non-votes.
- Approval of a grant of 10,204 Series A Convertible Preferred Shares to Anil Diwan in connection with his employment extension passed with 5,508,079 votes for, 844,079 against.
- Ratification of EisnerAmper LLP as independent registered public accounting firm for fiscal year ending June 30, 2024 passed with 9,165,259 votes for, 152,847 against.

## SEC filing metadata
- accession: 0001104659-24-005254
- form_type: 8-K
- ticker: NNVC
- cik: 0001379006
- company_name: NANOVIRICIDES, INC.
- filed_at: 2024-01-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1379006/000110465924005254/0001104659-24-005254-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1379006/000110465924005254/tm243719d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-005254
- JSON: https://secwatch.observer/filing/0001104659-24-005254.json
- Plain text: https://secwatch.observer/filing/0001104659-24-005254.txt

## Key facts
- Shareholder Votes
  NANOVIRICIDES, INC. shareholders approved Advisory vote on the compensation of the Company’s named executive officers at the 2024-01-13 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2024-01-13
  source text: Proposal 2 – Advisory Vote on Compensation of Named Executive Officers: Votes For Votes Against Votes Abstained Broker Non-Votes 5,572,378 788,423 25,933 3,056,966
  evidence_url: https://www.sec.gov/Archives/edgar/data/1379006/000110465924005254/0001104659-24-005254-index.htm
- Shareholder Votes
  NANOVIRICIDES, INC. shareholders approved Approval of an award of 10,204 Series A Preferred Shares to Anil Diwan in connection with the extension of his employment as the Company’s President at the 2024-01-13 meeting.
  - Outcome: passed
  - Meeting: 2024-01-13
  source text: Proposal 3 – Approval of Convertible Preferred Stock Grant to Anil Diwan: Votes For Votes Against Votes Abstained Broker Non-Votes 5,508,046 844,079 34,609 3,056,966
  evidence_url: https://www.sec.gov/Archives/edgar/data/1379006/000110465924005254/0001104659-24-005254-index.htm
- Shareholder Votes
  NANOVIRICIDES, INC. shareholders approved Re-election of Anil Diwan as a Class I Director for a two-year term expiring at the 2025 annual meeting of stockholders and until his successor is duly elected and qualified or until his earlier resignation or removal at the 2024-01-13 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-01-13
  source text: Proposal 1 – Election of Director - Re-Election of Anil Diwan as a Class I Director: Votes For Votes Against Votes Abstained Broker Non-Votes 5,590,467 308,092 488,175 3,056,966
  evidence_url: https://www.sec.gov/Archives/edgar/data/1379006/000110465924005254/0001104659-24-005254-index.htm
- Shareholder Votes
  NANOVIRICIDES, INC. shareholders approved Ratification of the appointment of EisnerAmper, LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2024 at the 2024-01-13 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2024-01-13
  source text: Proposal 4 – To ratify the appointment of EisnerAmper, LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2024: Votes For Votes Against Votes Abstained 9,165,259 152,847 125,594
  evidence_url: https://www.sec.gov/Archives/edgar/data/1379006/000110465924005254/0001104659-24-005254-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.